Le Yang

Dr. Le Yang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Brain Research Bulletin
Verified
Journal Article
Closed access
MGMei-Rong Gao
Mei-Rong Gao
MWMin Wang
Min Wang
YJYan-Yan Jia
Yan-Yan Jia
DTDan-Dan Tian
Dan-Dan Tian
ALAn Liu
An Liu
YWYu-Mei Wu
Yu-Mei Wu

21 December 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
FYFan Yang
Fan Yang
XWXinshang Wang
Xinshang Wang
JQJingyu Qi
Jingyu Qi
KZKun Zhang
Kun Zhang
YJYongli Jiang
Yongli Jiang
XMXue Ma
Xue Ma
Depression is a frequent and serious comorbidity associated with diabetes which adversely affects prognosis and quality of life. Glucagon-like peptide-1 receptor (GLP-1R) agonists, widely used in the treatment of diabetes, are reported to exert neuroprotective effects in the central nervous system. Thus, we aim to evaluate whether GLP-1R agonist exendin-4 (EX-4) could alleviate depression-like behaviors in diabetic mice and to explore its underlying mechanism. The antidepressant effects of EX-4 were evaluated using behavioral tests in db/db mice. The effects of EX-4 on microglial pyroptosis and neuroinflammation were assessed in N9 microglial cells. EX-4 administration alleviated depression-like behaviors in diabetic db/db mice. GLP-1R activation by EX-4 significantly suppressed microglial pyroptosis and neuroinflammation by downregulation of gasdermin D (GSDMD) and interleukin (IL)-1β in diabetic mice and lipopolysaccharide (LPS)-primed N9 microglia. Mechanistically, GLP-1R activation improved mitochondrial function and promoted mitophagy by decreasing the accumulation of mitochondrial reactive oxygen species (mtROS) and intracellular ROS production. EX-4 exhibits antidepressant effects in depression associated with diabetes in diabetic mice, which may be mediated by inhibiting microglial pyroptisis via promoting mitophagy. It is supposed that GLP-1R agonists may be a promising therapy in depression associated with diabetes.

24 May 2024 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
LLLi Luo
Li Luo
TYTao Yan
Tao Yan
LYLe Yang
Le Yang
MZMing-Gao Zhao
Ming-Gao Zhao
Alzheimer’s disease (AD) is an age-related neurodegenerative disorder. Transgenic and pharmacological AD models are extensively studied to understand AD mechanisms and drug discovery. However, they are time-consuming and relatively costly, which hinders the discovery of potential anti-AD therapeutics. Here, we established a new model of AD in larval zebrafish by co-treatment with aluminum chloride (AlCl3) and D-galactose (D-gal) for 72 h. In particular, exposure to 150 μM AlCl3 + 40 mg/mL D-gal, 200 μM AlCl3 + 30 mg/mL D-gal, or 200 μM AlCl3 + 40 mg/mL D-gal successfully induced AD-like symptoms and aging features. Co-treatment with AlCl3 and D-gal caused significant learning and memory deficits, as well as impaired response ability and locomotor capacity in the plus-maze and light/dark test. Moreover, increased acetylcholinesterase and β-galactosidase activities, β-amyloid 1–42 deposition, reduced telomerase activity, elevated interleukin 1 beta mRNA expression, and enhanced reactive oxygen species production were also observed. In conclusion, our zebrafish model is simple, rapid, effective and affordable, incorporating key features of AD and aging, thus may become a unique and powerful tool for high-throughput screening of anti-AD compounds in vivo.

1 January 2025 in Theranostics
Verified
Journal Article
Open access
PDF file
ADAohua Deng
Aohua Deng
RFRenming Fan
Renming Fan
YHYongrui Hai
Yongrui Hai
JZJunyan Zhuang
Junyan Zhuang
BZBingjie Zhang
Bingjie Zhang
GWGaofei Wei
Gaofei Wei
Rationale: Tumor-associated macrophages (TAMs) are abundant in colorectal cancer (CRC), correlating with immunosuppression and disease progression. Activation of the stimulator of interferon gene (STING) signaling pathway in TAMs offers a promising approach for CRC therapy. However, current STING agonists face challenges related to tumor specificity and administration routes.

29 March 2025 in Materials Today Bio
Verified
Journal Article
Open access
EZErman Zhao
Erman Zhao
XTXiuling Tang
Xiuling Tang
XLXitong Li
Xitong Li
JZJun Zhao
Jun Zhao
SWSaiying Wang
Saiying Wang
MZMing-Gao Zhao
Ming-Gao Zhao
Globally, more than 300,000 fatalities occur from burns annually, and burn-wound healing continues to present significant challenges owing to the wound's propensity for infections, heavy bleeding, poor angiogenesis, and persistent inflammatory responses. The immunomodulation of macrophage polarization toward the M2 phenotype facilitates the healing of burn wounds by controlling the tissue microenvironment and expediting the transition from the inflammatory phase to proliferation. Here, a polydopamine-mediated graphene oxide (GA), tannic acid (TA), and magnesium ion (Mg2+)-incorporated multifunctional gelatin (Gel) scaffold (GTMG) is developed to accelerate wound healing by modulating the inflammatory microenvironment of burn wounds. GA and Mg2+ confer the scaffold with the conversion of M1-type to M2-type macrophages and vascular regeneration. TA and GA synergistically provide with antimicrobial capabilities to the hydrogel. Additionally, the multifunctional hydrogel shows strong hemostatic, anti-inflammatory and biocompatible properties. Due to its strong tissue adhesion and injectability, the hydrogel can also be used for various forms of dynamic burn wounds. In vivo research shows that the hydrogel may have hemostatic, anti-inflammatory, and M2-phenotypic macrophage-polarization effects, which increase the regeneration and repair effects of burn sites and shorten the burn-healing time. The results indicate that this multifunctional hydrogel offers a promising therapeutic approach for the treatment of burn wounds by altering the immunological microenvironment and accelerating the three phases of wound healing.

20 May 2024 in Medcomm
Verified
Journal Article
Open access
RFRenming Fan
Renming Fan
ADAohua Deng
Aohua Deng
RLRuizhuo Lin
Ruizhuo Lin
SZShuo Zhang
Shuo Zhang
CCCaiyan Cheng
Caiyan Cheng
GWGaofei Wei
Gaofei Wei
Ferroptosis is an iron‐dependent cell death form that initiates lipid peroxidation (LPO) in tumors. In recent years, there has been growing interest on ferroptosis, but how to propel it forward translational medicine remains in mist. Although experimental ferroptosis inducers such as RSL3 and erastin have demonstrated bioactivity in vitro, the poor antitumor outcome in animal model limits their development. In this study, we reveal a novel ferroptosis inducer, oxaliplatin–artesunate (OART), which exhibits substantial bioactivity in vitro and vivo, and we verify its feasibility in cancer immunotherapy. For mechanism, OART induces cytoplasmic and mitochondrial LPO to promote tumor ferroptosis, via inhibiting glutathione‐mediated ferroptosis defense system, enhancing iron‐dependent Fenton reaction, and initiating mitochondrial LPO. The destroyed mitochondrial membrane potential, disturbed mitochondrial fusion and fission, as well as downregulation of dihydroorotate dehydrogenase mutually contribute to mitochondrial LPO. Consequently, OART enhances tumor immunogenicity by releasing damage associated molecular patterns and promoting antigen presenting cells maturation, thereby transforming tumor environment from immunosuppressive to immunosensitive. By establishing in vivo model of tumorigenesis and lung metastasis, we verified that OART improves the systematic immune response. In summary, OART has enormous clinical potential for ferroptosis‐based cancer therapy in translational medicine.